Digestive surgery biological patch and preparation method thereof
By optimizing the maximum tensile elongation, elastic deformation rate, and single-line suture traction of the biological patch, a biological patch suitable for digestive surgery was prepared, solving the problems of anastomotic bleeding and exudation, and achieving higher safety and healing effect.
Patent Information
- Application Number
- CN202411035176.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-30
AI Technical Summary
Complications such as anastomotic bleeding and exudation are frequent in digestive surgery. Existing biological patches have large fluctuations and instability in tensile strength, and cannot effectively prevent these complications.
By controlling the maximum tensile elongation, elastic deformation rate, and single-line suture traction force of the biological patch, optimized to a maximum tensile elongation of 14.8-44.6%, an elastic deformation rate of 13.7-39.1%, and a single-line suture traction force of 15.6-54.1N, and combined with an anastomosis device, surgical patches suitable for various parts of the digestive tract were prepared.
It significantly reduced the incidence of anastomotic bleeding and exudation, improved the safety and efficiency of the operation, and promoted tissue healing and repair.
Smart Images

Figure CN118903559A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a digestive surgery biological patch and a preparation method thereof. Background Art
[0002] Digestive tract tumors refer to a large class of benign and malignant tumors originating in the digestive tract. With the intensification of the aging trend of the population, the proportion of patients with digestive surgery tumors has gradually increased. Such patients often have poor tissue quality after radiotherapy and chemotherapy. During the operation, the anastomosis (the place where the stomach or esophagus and small intestine are sutured is called "anastomosis") is prone to complications such as bleeding at the cutting edge, bleeding, exudation, and anastomotic stenosis. These complications seriously increase the mental, physical, and economic burden on patients. In the field of digestive surgery, since there are many blood vessels involved in the operation, the most common complication is bleeding or bleeding during and after the operation. Intraoperative treatment of bleeding or bleeding will make the operation longer, cause greater damage to the patient, and use more medical supplies and equipment. Postoperative bleeding requires patients to be hospitalized for a longer period of time or even a second operation.
[0003] In order to deal with these complications, minimally invasive surgery has gradually become popular, among which staplers are commonly used surgical tools. Although minimally invasive surgery reduces surgical trauma to a certain extent, the problem of anastomotic complications still exists. The biological patch obtained from biomaterials has good elasticity and can tighten the anastomosis, reducing the incidence of complications such as anastomotic bleeding or anastomotic stenosis. Summary of the invention
[0004] Through research, the present invention finds that by controlling the four key parameter ranges of the maximum tensile elongation, elastic deformation rate, single-line suture pulling force, and the value of the elastic deformation rate to the maximum tensile elongation of the biological patch, the obtained biological patch can effectively reduce related complications such as anastomotic bleeding and gastric and intestinal fluid exudation during or after digestive surgery.
[0005] In the present invention, the determination of the maximum tensile elongation and the single-line suture pulling force refers to the existing literature (Li Chongchong, Liu Li, Wang Shuo, et al. Comparison of mechanical properties of allogeneic and animal-derived patches [J]. Beijing Biomedical Engineering, 2021.). The elastic deformation rate is determined using conventional determination methods in the field. The prepared biological patch is cut into a length of 4 cm and a width of 1 cm. The biological patch is clamped on a tensile testing machine along its length direction, and a tensile load is applied at a speed of 100 mm / min to stretch the biological patch until it breaks. The tensile curve is drawn, and the elastic deformation rate of the biological patch is calculated based on the elastic deformation section of the tensile curve.
[0006] As one aspect of the present invention, it relates to a digestive surgery biological patch, the maximum tensile elongation of the biological patch is not less than 14.8%, the elastic deformation rate range is not less than 13.7%, and the single-line suture pulling force is greater than 15.6N.
[0007] In a specific embodiment, the maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 13.7-39.1%, the single-line suture pulling force ranges from 15.6-54.1N, and the elastic deformation rate accounts for 39-89% of the maximum tensile elongation. It is suitable for surgical operations of the digestive tract colon and ileum.
[0008] In a specific embodiment, the maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate is 14.6-39.1%, the single-line suture pulling force is 15.6-54.1N, and the elastic deformation rate accounts for 50-89% of the maximum tensile elongation. It is suitable for surgical operations of the digestive tract and rectum.
[0009] In a specific embodiment, the maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 13.7-39.1%, the single-line suture pulling force ranges from 15.6-54.1N, and the elastic deformation rate accounts for 50-89% of the maximum tensile elongation. It is suitable for surgical operations on the digestive tract and duodenum. In a specific embodiment, the maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 14.6-39.1%, the single-line suture pulling force ranges from 19.7-54.1N, and the elastic deformation rate accounts for 56-89% of the maximum tensile elongation. It is suitable for surgical operations on the digestive tract and stomach, and can also be widely used in surgical operations on various parts of the digestive tract.
[0010] The digestive surgery biological patch is preferably a biological patch derived from bovine pericardium. The digestive surgery biological patch is provided with two perforations, and the two perforations are located at two opposite ends of the biological patch.
[0011] As another aspect of the present invention, it relates to a stapler set including the above-mentioned digestive surgery biological patch. Since digestive surgery cutting is mostly performed by cutting staplers, the application of the patch needs to be combined with the pre-installation of the stapler clip, that is, the patch is stretched and fixed to the two ends of the stapler clip before the operation.
[0012] As another aspect of the present invention, it relates to a method for preparing the above-mentioned digestive surgery biological patch, comprising the following steps:
[0013] (1) Immerse healthy bovine pericardial tissue in hypotonic Hank's solution, rinse and replace the hypotonic Hank's solution repeatedly to fully swell and break up the various cells in the tissue;
[0014] (2) The tissue slices treated as above are repeatedly rinsed with physiological saline for 60 min to 120 min each time, with the physiological saline changed each time. The total number of rinses is based on the fact that no visible cells, cell components or cell fragments can be seen under the microscope of the tissue slices, and protein and nucleic acid quantitative determination is performed until no soluble protein and nucleic acid can be detected;
[0015] (3) Using Tween 80, a surfactant solution, to remove phospholipids and nonstructural proteins in the tissue slices as well as some tissue matrix immunogenic molecules such as hyaluronic acid, various chondroitin sulfates, and mucopolysaccharides;
[0016] (4) Soak in a 0.5-1.5% glutaraldehyde solution for 3-3.5 hours;
[0017] (5) Place the pretreated tissue material in Cr 3+ The ion concentration is 0.0625 mol / dm 3 , OH / Cr is 0.5 in a hydroxychromium solution, shake in a water bath at 35-42℃ for 3.5-5h; detect the pH of the material treatment solution and use 10% NaHCO 3 The pH was raised by 0.3-0.5 units and then shaken in a water bath at 40-46°C for 60 min.
[0018] The biological patch provided by the present invention is used as a cushion for the cutting edge of the gastric and intestinal digestive tract tissues. Before the operation, it can be simply and stably pre-placed on the inner side of the clamping piece of the stapler. When clamping the tissues during the operation, the nail holes and sutures formed after the titanium nails of the stapler pass through the biological patch will shrink rapidly due to the elastic retraction deformation of the biological patch to prevent leakage. At the same time, the rebound deformation of the biological patch also makes the tissue clamping more stable and reliable, plays a role in sealing, and promotes the healing and repair of the cutting edge tissues, which can effectively prevent various complications such as esophageal leakage, gastric leakage and intestinal leakage caused by postoperative bleeding and exudation.
[0019] The biological patch provided by the present invention uses bovine pericardium as raw material, has excellent tissue compatibility, can promote tissue repair and healing, and can evenly distribute the stress squeezed by the titanium nail on the entire anastomotic suture nail, thereby reducing local tissue cutting force, effectively reducing the incidence of complications such as anastomotic bleeding and exudation, and simplifying surgical operations. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 Schematic diagram of pre-setting a biological patch on a stapler; wherein A is a biological patch with different perforation distances; B is a stapler without a pre-set biological patch; C is a biological patch pre-set with a stapler; and D is a partial enlarged view of point E in Figure C.
[0021] Figure 2 The following are the HE staining results of the white pig heart, liver, spleen and lung using the biological patch obtained in Example 1.
[0022] Figure 3 The HE staining results of the left kidney, right kidney and brain of a white pig using the biological patch obtained in Example 1 are shown.
[0023] Figure 4 The HE staining results of the white pig stomach, stomach surrounding tissue and intestine using the biological patch obtained in Example 1 are shown.
[0024] Figure 5 The HE staining result of the surrounding tissue of the white pig intestine using the biological patch obtained in Example 1 is shown.
[0025] Figure numerals: biological patch 1, perforation 2, stapler 3, clamping piece 4, nail magazine or titanium nail anvil 5. DETAILED DESCRIPTION
[0026] In the process of completing the present invention, the inventor firstly aimed at the problem that digestive surgery is prone to complications such as anastomotic bleeding and exudation, and referred to the existing literature (Li Chongchong, Liu Li, Wang Shuo, et al. Comparison of Mechanical Properties of Allogeneic and Animal-derived Patches [J]. Beijing Biomedical Engineering, 2021.), and used the tensile strength, maximum tensile elongation and single-line suture pulling force of the biological patch as parameters for screening biological patches, and the determination methods of each parameter refer to the literature. However, after the measurement, it was found that the tensile strength of the obtained biological patch fluctuated greatly and the value was unstable. In addition, it was found through animal experiments that the correlation between the tensile strength of the biological patch and anastomotic bleeding and exudation was unstable, and the tensile strength of the biological patch could not be used as a parameter for screening biological patches. Therefore, the inventor determined the screening evaluation parameters of the biological patch as the maximum tensile elongation, elastic deformation rate and single-line suture pulling force, and determined the preferred ranges of these three parameters through clinical trials as follows:
[0027] (1) Biological patches for colon and ileum surgery: maximum tensile elongation range 14.8-44.6%, elastic deformation range 13.7-39.1%, single-line suture pulling force 15.6-54.1N.
[0028] (2) Biological patches for rectal surgery: maximum tensile elongation range 14.8-44.6%, elastic deformation range 14.6-39.1% and single-line suture pulling force 15.6-54.1N.
[0029] (3) Biological patch for duodenal surgery: maximum tensile elongation range 14.8-44.6%, elastic deformation range 13.7-39.1% and single-line suture pulling force 15.6-54.1N.
[0030] (4) Biological patches for gastric surgery and general digestive surgery: maximum tensile elongation range 14.8-44.6%, elastic deformation range 14.6-39.1% and single-line suture pulling force 19.7-54.1N.
[0031] However, during this process, it was unexpectedly discovered that the value of the elastic deformation rate as a percentage of the maximum tensile elongation would also affect anastomotic bleeding and exudation.
[0032] The inventors have verified this discovery through clinical trials and confirmed that when the maximum tensile elongation, elastic deformation rate and single-line suture pulling force are within a specific range, controlling the value of the elastic deformation rate to the maximum tensile elongation will help reduce the occurrence of complications such as anastomotic bleeding and exudation in digestive surgery. The required elastic deformation rate to the maximum tensile elongation value for different surgical sites is as follows:
[0033] (1) Biological patches for colon and ileum surgery: The elastic deformation rate accounts for 39-89% of the maximum tensile elongation.
[0034] (2) Biological patches for rectal and duodenal surgery: The elastic deformation rate accounts for 50-89% of the maximum tensile elongation.
[0035] (3) Biological patches for gastric surgery and general digestive surgery: The elastic deformation rate accounts for 56-89% of the maximum tensile elongation.
[0036] 1. Preparation method of biological patch
[0037] (1) Pretreatment
[0038] In the present invention, the pretreatment specifically refers to the operation steps of decellularizing and removing immunogenicity of biological tissues, which is a conventional technical means in the art, and is aimed at removing cell tissue components and removing immunogenicity. The present invention does not limit the specific operation process. The specific operation process can be referred to as follows:
[0039] ① Immerse healthy bovine pericardial sheet tissue in hypotonic Hank's solution, rinse it several times and replace the hypotonic Hank's solution repeatedly to fully swell and break various cells in the tissue. The present invention selects bovine pericardial tissue.
[0040] ② Rinse the tissue slices after the above treatment repeatedly with physiological saline, each time rinsing with physiological saline for 60min-120min (for example, in a specific embodiment of the present invention, the preferred rinsing time with physiological saline is 60min), and change the physiological saline each time. The total number of rinsing times is based on the fact that no visible cells or cell components and cell fragments can be seen under the microscope of the tissue slices, and quantitative determination of protein and nucleic acid is performed until no soluble protein and nucleic acid can be detected.
[0041] ③ Use the surfactant solution Tween 80 to remove phospholipids and non-structural proteins in the tissue slices as well as some immunogenic molecules such as hyaluronic acid, various chondroitin sulfates and mucopolysaccharides.
[0042] ④ Soak in a 0.5-1.5% glutaraldehyde solution for 3-3.5 hours. In a specific embodiment of the present invention, the preferred glutaraldehyde soaking condition is: 0.5% glutaraldehyde solution for 3.5 hours.
[0043] (2) Chemical modification
[0044] The process of composite cross-linking modification of free carboxyl groups within and / or between tissue skeleton collagen molecules and between skeleton collagen and tissue matrix, so that the modified tissue slices obtain corresponding mechanical properties and anti-calcification properties. The cross-linking agent used in the present invention is a polymer of hydroxychromium coordination compound. The specific operation can be referred to as: placing the pretreated tissue material in Cr 3+ The ion concentration is 0.0625 mol / dm 3 , OH / Cr is 0.5, and the first water bath oscillation is performed under the conditions of 35-42°C for 3.5-5h (for example, the first water bath oscillation condition used in a specific embodiment of the present invention is 35°C water bath oscillation for 3.5h). Detect the pH of the material treatment solution and use 10% NaHCO 3 Increase 0.3-0.5 pH units (for example, one embodiment of the present invention preferably uses 10% NaHCO 3 The pH value is increased by 0.3 pH units), and then a second water bath oscillation is performed at 40-46°C for 60-120 min (for example, the first water bath oscillation condition preferably adopted in a specific embodiment of the present invention is 40°C water bath oscillation for 60 min), and finally a single-layer biological patch is obtained.
[0045] The obtained biological patch has a rough surface on one side and a smooth surface on the other side. Figure 1 As shown, the obtained biological patch 1 is provided with more than two perforations 2 with the same direction and slightly smaller than the width of the clamping sheet 4, so that the free end of the clamping sheet 4 passes through two of the perforations 2 in sequence (the distance between the two perforations 2 is selected according to the surgical needs), and the position of the biological patch 1 is further adjusted by manual operation, so that the biological patch 1 is flatly laid on the inner side of the clamping sheet 4, and the rough surface contacts the stapler or stapler anvil 5 of the stapler, and there is a large friction after contact, so that the biological patch 1 is not easy to slip off when the stapler 3 cuts and staples; the smooth surface fits the digestive tissue to ensure the fit with the digestive tissue. The size of the perforation 2 is slightly smaller than the width of the clamping sheet 4 to ensure that the biological patch 1 remains in a stretched state when hanging on the clamping sheet 4, and does not slide or slip off the clamping sheet 4.
[0046] Examples 1-17
[0047] Table 1: Main differences in the preparation methods of Examples 1-17
[0048]
[0049]
[0050] 2. Determination of tensile strength, maximum tensile elongation and single-line suture pulling force
[0051] Good mechanical properties can reduce the incidence of complications such as anastomotic bleeding and exudation, improve the compliance of biological patches, and improve the comfort of patients. In order to explore the relationship between mechanical parameters and bleeding, exudation, compliance, and comfort of gastroenterology biological patches, the inventors first consulted the literature and measured the biological patches obtained in Examples 1-17 based on existing literature (Li Chongchong, Liu Li, Wang Shuo, et al. Comparison of mechanical properties of allogeneic and animal-derived patches [J]. Beijing Biomedical Engineering, 2021.).
[0052] The present invention prepares 17 batches of biological patches through Examples 1-17, and obtains 10 biological patches in each batch (Example). The parameters are measured respectively with reference to the above literature, and the average values are taken to obtain the tensile strength, maximum tensile elongation and single-line suture pulling force of the biological patches. The measurement results are shown in Table 2 below:
[0053] Table 2: Maximum tensile elongation, tensile strength and single-line suture pulling force of Examples 1-17
[0054]
[0055]
[0056] It can be seen from Table 2 that in Examples 1-17, the tensile strength of the 10 biological patches obtained in the same batch in each Example fluctuates greatly and the values are unstable. This may be because there are other influencing factors on the tensile strength of the patch that the inventors have not discovered, making it impossible to accurately control the tensile strength of the biological patch, which is not suitable for use as a surgical material.
[0057] Summarizing the mechanical parameters obtained by the above preparation method, it can be seen that the maximum tensile elongation of the biological patch obtained by the present invention is in the range of 11.1-44.6%, the tensile strength is 20.3-37.5MPa, and the single-line suture pulling force is in the range of 15.6-54.1N.
[0058] The 10 biological patches obtained in each example were cut into pieces with a length of 4 cm and a width of 1 cm, and tested to see whether they could be pre-set on the anastomosis device.
[0059] The biological patch needs to be properly stretched when it is pre-installed on the stapler, which is related to the maximum tensile elongation. In theory, the larger the maximum tensile elongation, the better. If the maximum tensile elongation is too small, the biological patch will break when stretched a small distance. For example, 10 biological patches obtained in Example 17 (maximum tensile elongation of 11.1±0.4%) were assembled with the stapler, and it was found that 9 were torn and 1 had obvious cracks. This reflects the toughness of the biological patch, which is extremely difficult to deform, and quickly enters permanent deformation and breaks after deformation.
[0060] It is found that the biological patch with a maximum tensile elongation of 11.1% cannot meet the requirements for installation on the stapler. Based on the fact that the biological patches obtained in other embodiments meet the tensile requirements and can be pre-installed on the stapler, the maximum tensile elongation of the patch obtained in Example 2 is 14.8±0.5%, which is the minimum value of the maximum tensile elongation that meets the requirements for installing the biological patch on the stapler. Animal experiments were conducted on the embodiments (Examples 1-16) that meet the requirements for pre-installation on the stapler.
[0061] 3. Animal Experiments
[0062] The gastrointestinal tract of white pigs has many similarities with that of humans in terms of anatomical structure and physiological function, making them an ideal animal model for studying human gastrointestinal diseases and injuries. White pigs are of moderate size, making them easy to operate and manage in experiments. Compared with small animals such as mice and rats, white pigs provide a larger operating space, allowing researchers to perform surgical operations more easily. At the same time, white pigs are easy to raise and manage under laboratory conditions, are less susceptible to postoperative infection, are easier to control in long-term breeding, and have a high long-term survival rate.
[0063] Healthy experimental animals were purchased according to SOP-5 experimental animals and receiving operating procedures. The experimental animals were provided by Jiangxi Yinshe Biotechnology Co., Ltd. (license number SCXK (Gan) 2023-0002). All animals were used for animal experiments for the first time at the beginning of the experiment. All experimental animals were quarantined before surgery, and only those that passed the quarantine were included in this study.
[0064] Inclusion Criteria
[0065] Meet the requirements of the national "Animal Quarantine Management Measures"; weigh 50-60kg; normal physiological indicators; no obvious serious animal diseases (such as active digestive diseases, blood system and metabolic system diseases, infectious diseases and zoonoses, etc.).
[0066] Feeding
[0067] The experimental animals were tracked and managed according to the SMP-5 experimental animal care management regulations. The experimental animals were given appropriate amounts of feed twice a day. The animals could drink water freely through the automatic water supply system. Both feed and water were clean and safe.
[0068] Grouping and quantity
[0069] 1-month group: 48 rats in total (16 examples, 3 rats in each example were used for the experiment); 3-month group: 48 rats (16 examples, 3 rats in each example were used for the experiment). Gender was not limited, and the rats were randomly divided into groups.
[0070] During the experiment, animal information was recorded: body weight, surgery time, survival days, biological patch information, etc.
[0071] Measure blood routine, blood biochemistry, coagulation function, and blood gas before surgery.
[0072] Blood routine, blood biochemistry, coagulation function, and blood gas were measured 1 month and 3 months after surgery.
[0073] Experimental procedures
[0074] ①Preoperative preparation;
[0075] ②Perform preoperative blood tests according to routine examination requirements and record preoperative data;
[0076] ③During the operation, the experimental pigs were placed under general anesthesia, intubated, ventilated with a ventilator, and the skin was disinfected and prepared.
[0077] ④ Supine position, open the abdomen to expose the abdomen, free the gastric tissue, select a suitable position, and make an incision smaller than the size of the biological patch; Figure 2 As shown in the figure, a 1cm×4cm biological patch is installed on the stapler, and the stapler with the pre-installed biological patch is placed in the predetermined position, and its angle and depth are adjusted to ensure close fit with the surrounding tissue. The gastric anastomosis and patch are carefully inspected to observe whether the biological patch and digestive tissue are well anastomosed, whether the resilience of the biological patch meets the requirements, whether the biological patch is fixed and stable, and whether there is bleeding and exudation at the nail holes and sutures.
[0078] ⑦ Select a suitable position at the location where the small intestine is freed from the abdominal cavity, cut an incision smaller than the size of the patch, install a 1cm×4cm biological patch on the stapler, place the stapler with the pre-installed biological patch at the predetermined position, and adjust its angle and depth to ensure that it fits tightly with the surrounding tissue. ⑧ Carefully inspect the intestinal anastomosis and patch to observe whether the biological patch and digestive tissue fit well, whether the resilience of the biological patch meets the requirements, whether the biological patch is fixed and stable, and whether there is bleeding at the nail holes and suture needle holes. ⑨ After the operation is completed, check the anastomosis again for bleeding, exudate, etc. After confirmation, close the abdomen.
[0079] After surgery, the animals were sent to the observation room for observation. The animals were supported by a ventilator until they woke up and could stand and move, then sent to the animal room for feeding. The lighting was alternating 12h / 12h every day. The animals were fed an appropriate amount of feed once in the morning and afternoon, and were allowed to drink water freely. The mental state, appetite, breathing, wound complications and other adverse symptoms were observed daily.
[0080] Postoperative care: Continuous intramuscular injection of 2g of ceftriaxone sodium for one week for anti-infection. Observe the mental state, appetite, breathing, wound healing status, nausea, vomiting and other gastrointestinal symptoms of the animal every day. Disinfect the surgical wound with iodine until the wound heals. Veterinarians perform regular physical examinations and blood tests, and take anti-infection prevention and treatment measures based on the results. Record postoperative medication and adverse events within 24 hours (including death, infection, etc.).
[0081] From the experimental animals that reached the endpoint, gross group tissues (heart, liver, spleen, lung, kidney, brain), stomach patch and surrounding tissues, intestinal patch and surrounding tissues were observed with the naked eye and photographed. Tissues were then fixed in 10% formalin for 48 hours, routinely sectioned, and HE stained.
[0082] The integrity of the patch, defects and leakage of the patch, thrombus on the surface, and bleeding, necrosis and other changes in the surrounding tissues were observed with the naked eye. The test animals were killed 1 and 3 months after surgery, and the pathological results of the test animals that reached the endpoint were recorded.
[0083] Table 4: Pathological scoring principles
[0084]
[0085] 5. Experimental Results
[0086] (1) In total, pigs using the biological patches obtained from 11 examples did not experience bleeding or exudation at the gastric or intestinal anastomosis, namely, Example 1, Example 5, Examples 7-9, and Examples 11-16.
[0087] The experimental animals in the above experimental groups all successfully completed the digestive surgery gastrointestinal anastomosis surgery, the biological patch fits tightly with the anastomosis, the bleeding at the anastomosis and surrounding tissues can be effectively controlled in a timely manner, and no instrument failure of the stapler and components occurred during the operation. The anesthesia, gastrointestinal anastomosis process was smooth, and there was no bleeding or exudation at the anastomosis during the operation; the vital signs were normal; and no adverse events occurred.
[0088] The animals were generally in good condition during the survival and breeding period, with normal body temperature, diet, and excretion, good autonomous activities, and no obvious abnormal manifestations such as weight loss, fever, anorexia, and mania. They survived to the end successfully without complications such as bleeding, infection, anastomotic stenosis, rejection reaction, and organ failure.
[0089] After the autopsy, the thoracic cavity was intact, without pleural effusion, and no obvious pathological changes were found in the chest wall and thoracic contents; the abdominal cavity was intact, without ascites, and no obvious abnormal pathological changes were found in the abdominal wall, peritoneum, abdominal contents, and intestinal tract; no changes related to the biological patch surgery were found in the heart, liver, spleen, lung, kidney, brain, stomach, and intestinal specimens.
[0090] During the follow-up period after the extracardiac radiofrequency ablation surgery, the electrolytes and liver and kidney function values were almost within the normal range, and the coagulation INR value was around 1.0 before and during the follow-up period. There were no abnormalities in the number, morphology, and quality of whole blood cells; the results of white blood cells, red blood cells, hemoglobin, platelets, etc. showed that the overall results were stable, and no abnormalities were found in important blood routine indicators. No abnormal liver or kidney function was found, and some values were slightly higher or lower than the reference value range, but they were not clinically significant. Before surgery and before the end of the trial, normal laboratory test results were considered to be clinically significant.
[0091] The results of the intraoperative anatomical comparison and analysis of the gastrointestinal anastomosis showed that the anastomosis of the stomach and intestine was smooth and good, without bleeding or exudate. At the end of the follow-up of 1 month and 3 months, the surface of the gastric anastomosis formed scar tissue to prevent leakage and promote healing, and was not decomposed. In the small intestine, due to the flow of food and digestive fluid, the biological patch is more susceptible to physical and chemical effects, which accelerates the degradation process. When the biological patch is implanted into the small intestinal anastomosis, it can act as a scaffold, and the degraded material can be absorbed or replaced by new cells, thereby promoting the complete healing of the anastomosis. This shows that the biological patch can slowly decompose and regenerate at the anastomosis of the small intestine of the white pig, mainly because of the interaction between its material properties and the physiological environment of the tissue. At the anastomosis on the surface of the stomach, due to its different physiological environment from the small intestine and the interaction of gastric acid and pepsin, the biological patch may not decompose or decompose slowly, reflecting the good biocompatibility of the digestive surgery biological patch and its ability to form a good combination with the surrounding tissue.
[0092] Figure 2 The following are the HE staining results of the white pig heart, liver, spleen and lung using the biological patch obtained in Example 1. Figure 2 A- Figure 2 As shown in B, a small amount of myocardial cells with watery degeneration (blue arrows) can be seen in the heart tissue, with swollen cell bodies, loose and lightly stained cytoplasm, no obvious proliferation of the interstitium, and no obvious necrosis and inflammatory cell infiltration. Figure 2 C- Figure 2As shown in D, the liver tissue hepatic lobules are clearly demarcated and arranged regularly. The central vein is in the center of the hepatic lobule, and the surrounding hepatocytes and hepatic sinusoids are arranged roughly radially. A small number of hepatocytes are slightly fatty (yellow arrows), and round microvesicles can be seen in the cytoplasm. A small number of hepatocytes are edematous (blue arrows), and the cells are swollen with loose and lightly stained cytoplasm. A small number of lymphocyte infiltration can be seen around the portal area (red arrows). Figure 2 E- Figure 2 As shown in F, the white pulp of the spleen is abundant, of varying sizes and irregular shapes; the red pulp is distributed in a large area under the capsule, around the trabeculae and outside the marginal zone of the white pulp, and is composed of splenic cords and splenic sinusoids. A small number of granulocytes can be seen in the marginal zone and the red pulp (red arrows). Figure 2 G- Figure 2 As shown in H, a small number of epithelial cells with pyknosis of the nuclei (black arrows) can be seen in a small number of bronchioles in the lung tissue, and the epithelial cells are arranged irregularly; a small amount of granulocyte infiltration can be seen in the alveolar wall (red arrows), and more alveoli are compensatory dilated.
[0093] Figure 3 The HE staining results of the left kidney, right kidney and brain of a white pig using the biological patch obtained in Example 1 are shown in FIG. Figure 3 A- Figure 3 As shown in B, the glomeruli are evenly distributed in the cortex of the renal tissue, the number of cells and matrix in the glomeruli are uniform, and there is little eosinophilia in the renal capsule (black arrow); a small number of tubular epithelial cells can be seen to have hydropic degeneration (blue arrow), swollen cells, and loose and lightly stained cytoplasm; a small number of tubular epithelial cells can be seen to have vacuolar degeneration (yellow arrow), and small round vacuoles appear in the cytoplasm; there is no obvious hyperplasia of the interstitium, and no obvious necrosis and inflammatory cell infiltration and other abnormalities are observed. Figure 3 C and Figure 3 As shown in D, glomeruli are evenly distributed in the cortex of renal tissue, the number of cells and matrix in the glomeruli are uniform, and there is little eosinophilia in the renal capsule (black arrow); many tubular epithelial cells are hydropic (blue arrow), the cells are swollen, and the cytoplasm is loose and lightly stained; lymphocyte infiltration is occasionally seen in the interstitium (red arrow); there is no obvious proliferation of the interstitium. Figure 3 E and Figure 3 As shown in F, the brain tissue is rich in neurons, and many neuronal nuclei are wrinkled and darkly stained (black arrows). The cell bodies are shrunk and deformed, with irregular shapes, and the boundary between the nucleus and cytoplasm is unclear. No obvious necrosis or inflammatory cell infiltration is observed.
[0094] Figure 4 The HE staining results of the white pig stomach, stomach surrounding tissue and intestine using the biological patch obtained in Example 1 are shown in FIG. Figure 4 A- Figure 4As shown in B, the gastric tissue structure is disordered, with a large area of patch (black arrow), a large amount of connective tissue hyperplasia (brown arrow) around the patch, a small amount of new blood vessels (green arrow), a large amount of lymphocyte infiltration (red arrow), and occasional endothelial cell hyperplasia (orange arrow). Figure 4 C- Figure 4 As shown in D, there is no obvious mucosal layer in the gastric tissue, but the muscular layer is well developed, with many muscle cells showing watery degeneration (blue arrows), loose and lightly stained cytoplasm, and no obvious inflammatory cell infiltration. Figure 4 E- Figure 4 As shown in F, intestinal villi are distributed on the surface of the intestinal tissue, and a large number of intestinal villus epithelial cells are missing (brown arrows), and the lamina propria is exposed; in the lamina propria, the intestinal glands are arranged loosely and irregularly, goblet cells are scattered, and a large number of lymphocytes are scattered in the interstitium (red arrows), and a large amount of vascular congestion can be seen (green arrows); a large number of connective tissue hyperplasia can be seen around the muscular layer (orange arrows), fibroblasts, fibroblasts and collagen fibers are arranged loosely and irregularly, a small number of new blood vessels can be seen, and vascular congestion can be seen, accompanied by a small amount of scattered lymphocyte infiltration (yellow arrows).
[0095] Figure 5 The HE staining results of the surrounding tissue of the white pig intestine using the biological patch obtained in Example 1 are shown in FIG. Figure 5 A- Figure 5 As shown in B, the surface of intestinal tissue is mainly composed of columnar epithelium and goblet cells, with goblet cells scattered. Many mucosal epithelial cells are shed (black arrows), exposing the lamina propria. The intestinal glands are arranged loosely and irregularly. Many lymphocytes are scattered in the interstitium (red arrows).
[0096] (2) No obvious tearing occurred at the nail holes and sutures of the biological patches obtained by using Examples 1-16. Therefore, the biological patches with a single-line suture pulling force ranging from 15.6 to 54.1 N can preliminarily meet the use requirements of digestive surgery.
[0097] (3) The anastomotic sites of the biological patches obtained by using Examples 2-4, Example 6 and Example 10 showed bleeding and exudation, and some experimental groups even showed degeneration, hyperplasia and very serious tissue necrosis. Among them, the biological patch obtained by Example 3 showed anastomotic bleeding and exudation after surgery. One month after the surgery, the hearts of two pigs showed degeneration, hyperplasia and very serious tissue necrosis, the spleen showed relatively serious tissue necrosis, and the gastric patch and intestinal patch showed serious connective tissue hyperplasia. The specific pathological scoring results are as follows:
[0098] Table 5: Pathological results of Example 3 at 1 month
[0099]
[0100]
[0101]
[0102] (4) In theory, the biological patch pre-installed on the anastomosis device needs to have a certain tensile strength to help ensure the compliance of the biological patch and prevent anastomotic bleeding and exudation. However, in animal experiments, it was found that:
[0103] Specifically, among the 10 biological patches obtained in Example 10 (tensile strength 20.7±3.3MPa), one biological patch in the experimental group had anastomotic bleeding and exudation. However, the examples with similar tensile strength to this example did not have anastomotic bleeding and exudation, such as Example 8 (tensile strength 21.1±2.8MPa) and Example 13 (tensile strength 22.9±0.4MPa).
[0104] Among the 10 biological patches obtained in Example 6 (tensile strength 29.6±1.3MPa), 4 biological patches corresponding to the experimental groups showed anastomotic bleeding and exudation. However, the examples with similar tensile strength to this example did not show anastomotic bleeding and exudation, such as Example 9 (tensile strength 29.3±1.1MPa) and Example 11 (tensile strength 31.1±1.7MPa).
[0105] Among the 10 biological patches obtained from Example 2 (tensile strength 27.4±2.1MPa), Example 3 (tensile strength 31.8±2.5MPa) and Example 4 (tensile strength 30.7±4.4MPa), 7 of the experimental groups corresponding to the biological patches experienced anastomotic bleeding and exudation, but the embodiments with similar tensile strength to several embodiments did not experience anastomotic bleeding and exudation, such as Example 12 (tensile strength 28.2±1.8MPa) and Example 15 (tensile strength 26.1±3.2MPa), such as Example 1 (tensile strength 32.3±1.8MPa), Example 7 (tensile strength 33.5±0.9MPa), and Example 16 (tensile strength 37.5±1.8MPa).
[0106] The above experiments found that the maximum tensile elongation range of 14.8-44.6% can meet the requirements for installation on the stapler.
[0107] Since the tensile strength of the biological patch has large numerical fluctuations, and animal experiments have found that the correlation between the tensile strength of the biological patch and anastomotic bleeding and exudation is unstable, the inventors speculate that the tensile strength of the biological patch cannot be used as a parameter for screening biological patches, and the mechanical parameters that can indicate anastomotic bleeding and exudation need to be reconsidered.
[0108] Based on the inventors of this application's many years of research on the application of animal-derived biomaterials in digestive surgical implantation, the inventors found that the inability to perfectly match the height of the staples with the thickness of the tissue can lead to anastomotic bleeding and exudation. The staple height is fixed, but the thickness of tissues in different patients and different parts is different. When the tissue is too thick or too thin relative to the staple height, it may cause anastomotic bleeding and exudation. Therefore, the biological patch needs to have good resilience. The inventors want to introduce "elasticity" into the biological patch of biological origin, and replace "tensile strength" with "elastic deformation rate". The three mechanical parameters of elastic deformation rate, maximum tensile elongation and single-line suture pulling force are combined to continue to explore digestive surgical biological patches that prevent anastomotic bleeding and exudation.
[0109] 4. Determination of elastic deformation rate
[0110] 1. Determination method
[0111] A 4 cm long and 1 cm wide biological patch was clamped on a tensile testing machine along the length direction, and a tensile load was applied at a speed of 100 mm / min to stretch the biological patch until it broke. A tensile curve was drawn, and the elastic deformation rate of the biological patch was calculated based on the elastic deformation section of the tensile curve during the test.
[0112] 2. Measurement results
[0113] Table 3: Elastic deformation rate of Examples 1-17
[0114] Group Elastic deformation rate Group Elastic deformation rate Example 1 39.1±0.4% Example 10 10.2±1.3% Example 2 6.5±0.1% Embodiment 11 18.7±0.4% Example 3 4.4±0.7% Example 12 27.4±0.5% Example 4 5.2±0.1% Embodiment 13 16.1±1.2% Example 5 13.7±0.3% Embodiment 14 19.8±0.9% Example 6 7.6±0.2% Embodiment 15 23.5±0.3% Example 7 15.2±1.7% Example 16 14.6±1.6% Example 8 21.5±0.4% Embodiment 17 8.2±0.4% Example 9 13.9±1.1%
[0115] It can be found from Table 3 that the elastic deformation rates of the biological patches obtained in Examples 1-17 are relatively stable, and the elastic deformation rate ranges from 4.4 to 39.1%.
[0116] Based on the experimental results of animal experiments, the inventor unexpectedly found that 7 pigs had bleeding and exudation when using the biological patches obtained by Example 3 (elastic deformation rate 4.4±0.7%), Example 4 (elastic deformation rate 5.2±0.1%) and Example 2 (elastic deformation rate 6.5±0.1%); 4 pigs had bleeding and exudation when using the biological patch obtained by Example 6 (elastic deformation rate 7.6±0.2%); and only 1 pig had bleeding and exudation when using the biological patch obtained by Example 10 (elastic deformation rate 10.2±1.3%). That is, with the increase of elastic deformation rate, the number of pigs with anastomotic bleeding and exudation continued to decrease, and the elastic deformation rates of the biological patches obtained by these examples were lower than those of the examples without anastomotic bleeding and exudation.
[0117] Therefore, the inventors speculate that the greater the elastic deformation rate, the less likely it is that anastomotic bleeding and exudation will occur. Based on the experimental results of animal experiments, it can be preliminarily proved that the inventors’ introduction of “elastic deformation rate” is correct. It is speculated that the reason for the occurrence of anastomotic bleeding and exudation is that the biological patch has poor resilience, slightly poor adhesion to the pig’s tissue, and insufficient contraction elasticity at the nail holes and sutures, resulting in anastomotic bleeding and exudation. In addition, based on the animal experiments of the biological patches obtained using Examples 1, 5, 7-9, and 11-16, the range of the elastic deformation rate should be controlled within 13.7-39.1%.
[0118] V. Clinical Trial 1
[0119] 1. Inclusion criteria, exclusion criteria and total number of cases included
[0120] (1) Inclusion criteria
[0121] ① Age: 18 to 75 years old, regardless of gender; ② Meet the clinical surgical indications, and various digestive tract diseases require surgical esophageal, gastric, and intestinal cutting, closure, and anastomosis (no requirement for surgical approach, traditional open, laparoscopic, or robotic); ③ Be able to understand the purpose of the trial, voluntarily participate and sign the informed consent form, and be willing to accept relevant examinations and clinical follow-up.
[0122] (2) Exclusion criteria
[0123] ① Eastern Cooperative Oncology Group (ECOG) performance status score greater than or equal to 2 points. The ECOG performance status score is a scoring system used to assess the ability of cancer patients to carry out daily activities and self-care; ② American Society of Anesthesiologists (ASA) grade III or above (excluding grade III); ③ Autoimmune disease or blood system disease; ④ Diagnosis of clear abdominal infection; ⑤ Alanine aminotransferase or aspartate aminotransferase / aspartate aminotransferase greater than 2.5 times the upper limit of normal or total bilirubin greater than 1.5 times the upper limit of normal or less than serum creatinine greater than 1.5 times the upper limit of normal; ⑥ Hemoglobin level <60g / L or platelet level <100×10 9 / L or serum albumin less than 30g / L; ⑦ Any one of the coagulation function indicators exceeds the normal reference range of ±10%, including activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), and international normalized ratio (INR); ⑧ Severe liver disease, severe kidney disease, severe respiratory disease, or uncontrolled chronic systemic diseases such as diabetes, hypertension, and arrhythmia; ⑨ Myocardial infarction within 6 months; ⑩ Preoperative chemotherapy or chemoradiotherapy within 4 weeks; Pregnant women, breastfeeding women, or women who plan to become pregnant during the trial; Currently participating in clinical trials of other drugs or medical devices and the primary study endpoint has not yet been reached; Other circumstances assessed by the investigator as unsuitable for participation in this clinical trial.
[0124] 2. Experimental Grouping
[0125] Experimental group: divided into 11 groups, respectively, the biological patches obtained in Example 1, Example 5, Examples 7-9, and Examples 11-16 were used for surgery. Before the surgery, the biological patches were pre-placed on the stapler to perform the surgery.
[0126] Control group: The surgery was performed using only stapler closure / anastomosis.
[0127] 3. Test process
[0128] (1) Sign the informed consent form; (2) Screen the cases, confirm the clinical inclusion criteria, and simultaneously complete the baseline data collection; (3) Determine the operation time; (4) Enroll the subjects in the experimental group or the control group according to the random grouping; (5) Perform the operation; (6) Observe the bleeding points and record them in the operation report; (7) Evaluate the immediate postoperative condition of the subjects; (8) Complete the follow-up of the subjects before discharge, 1 month after surgery, and 3 months after surgery according to the relevant examination requirements in the protocol. Please refer to the table below for the specific process.
[0129] Table 6: Main test process
[0130]
[0131] 4. Efficacy indicators
[0132] (1) The number of bleeding points per unit length of the anastomosis / closed stoma that require clinical hemostasis and suture reinforcement within 10 minutes after the stapler is fired to complete cutting, closing, and anastomosis (after cutting, closing, and anastomosis, the researcher observes until no new bleeding points are added to the anastomosis as defined in the protocol) (observation sites: gastric resection stump, duodenal closed stump, intestinal closed stump, gastrointestinal anastomosis, esophageal anastomosis, esophagogastric anastomosis, esophagojejunal anastomosis, intestinal anastomosis, etc.).
[0133] The number of bleeding points per unit length of snout / closed mouth = total bleeding points (number) / cut edge length (cm).
[0134] Judgment criteria: ① Visit time point: Visit 1 (the day of surgery); ② Bleeding points that require clinical treatment: within 10 minutes after the completion of cutting, closure, and anastomosis (after the completion of cutting, closure, and anastomosis, the researcher observed until there were no new bleeding points defined in the protocol at the anastomosis), and the site where the cutting edge of the stapled tissue required additional clinical hemostasis, suture reinforcement, and treatment (such as manual pressure suture, hemostatic clips, or electrocoagulation).
[0135] (2) Within 10 minutes after the completion of cutting, closure, and anastomosis (after the completion of cutting, closure, and anastomosis, the researcher observed until no new pulsating bleeding points as defined in the protocol were observed at the anastomotic site), the number of arterial pulsating bleeding points per unit length of the anastomotic / closed site that required clinical hemostasis (observation sites: gastric resection stump, duodenal closed stump, intestinal closed stump, gastrointestinal anastomosis, esophageal anastomosis, esophagogastric anastomosis, esophagojejunostomy, intestinal anastomosis, etc.); the treatment time of bleeding points at the anastomotic / suture site (s); the total operation time (min) (from the start of the operation to the completion of abdominal closure).
[0136] Judgment criteria: Visit time point: Visit 1 (the day of surgery); Pulsating bleeding point: small artery bleeding, record the bleeding point (take photos). Bleeding point treatment time (s): the time recorded from the start of the intervention to the total time required for the completion of the hemostasis operation. If multiple hemostasis treatments are performed on the same bleeding point, the bleeding point treatment time is the sum of the multiple hemostasis treatment times.
[0137] (3) Safety evaluation indicators
[0138] ① The occurrence of anastomotic-related postoperative complications (anastomotic bleeding, anastomotic leakage, anastomotic stenosis) within 90 days after surgery. Specifically, the following complications are included:
[0139] A. Anastomotic bleeding: refers to persistent or intermittent bloody stools in patients after gastrointestinal reconstruction surgery. When massive bleeding causes hemodynamic disorders, symptoms such as tachycardia, hypotension, decreased hemoglobin levels, and even decreased urine volume may occur. If there is massive bleeding in the abdominal cavity, it will also cause abdominal distension.
[0140] B. Anastomotic leakage: refers to the leakage of food residues or digestive fluid into the abdominal cavity due to poor healing or loose anastomosis at the esophagus-stomach, esophagus-jejunum, stomach-duodenum, stomach-jejunum or jejunum-jejunum anastomosis during digestive tract reconstruction.
[0141] C. Anastomotic stenosis: Anastomotic stenosis: In the upper gastrointestinal tract, it means that the anastomosis cannot pass a thin-diameter endoscope with a diameter of 7.9 mm, accompanied by difficulty in swallowing; in the lower gastrointestinal tract, it means that the anastomotic stoma cannot pass a fiber colonoscope with a diameter of 13 mm, accompanied by difficulty in defecation.
[0142] ②Measurement method: Determine and record the occurrence of the above complications according to routine clinical methods.
[0143] ③ Visit time points: Visit 1 (surgery day), Visit 2 (before discharge), Visit 3 (30 days ± 10 days after surgery), Visit 4 (3 months ± 14 days after surgery).
[0144] 6. Test methods
[0145] Prospective, multicenter, randomized controlled, open, and superior.
[0146] 7. Test results
[0147] (1) Security
[0148] All patients had no complications of anastomotic bleeding, anastomotic leakage, and anastomotic stenosis within 90 days after surgery.
[0149] (2) Record of surgical bleeding points
[0150] Table 7: Bleeding point record of colon surgery
[0151]
[0152]
[0153]
[0154] Note: The biological patches obtained in each example are numbered 1-10 respectively; "Test Group 1 (Example 1-1)" means that Test Group 1 uses patch No. 1 obtained in Example 1; "Test Group 2 (Example 1-2)" means that Test Group 2 uses patch No. 2 obtained in Example 1.
[0155] The experimental results in Table 7 show that by comparing test group 9 (Example 9-1), test group 10 (Example 9-2), test group 3 (Example 5-1) and test group 4 (Example 5-2), it was found that the elastic deformation rate of the biological patch obtained in Example 5 (elastic deformation rate 13.7±0.3%) was similar to that of the biological patch obtained in Example 9 (elastic deformation rate 13.9±1.1%), but test group 9 (Example 9-1) and test group 10 (Example 9-2) had more bleeding points and / or pulsating bleeding points that required clinical hemostasis treatment, so the inventors speculate that the reason for the bleeding points is not only due to the low elastic deformation rate.
[0156] By further comparison, the inventor unexpectedly found that the value of elastic deformation rate of the biological patch obtained in Example 5 as a percentage of the maximum tensile elongation is greater than that of the biological patch obtained in Example 9 as a percentage of the maximum tensile elongation. The inventor speculated that there is a certain correlation between the value of elastic deformation rate as a percentage of the maximum tensile elongation and the clinical results, and further verified it in clinical experiments. And based on Example 13 (elastic deformation rate as a percentage of the maximum tensile elongation of 39%), the value of elastic deformation rate as a percentage of the maximum tensile elongation of colon surgery was boldly set to be no less than 39%.
[0157] Table 8: Values of elastic deformation ratio of the biological patch obtained in Examples 1-17 as a percentage of the maximum tensile elongation
[0158]
[0159]
[0160] The elastic deformation rate of the biological patch obtained in Examples 1-17 accounts for the value of the maximum tensile elongation in the range of: 20-89%
[0161] Table 9: Record of bleeding points during rectal surgery
[0162]
[0163]
[0164] The experimental results in Table 9 show that more bleeding points and / or pulsating bleeding points requiring clinical hemostasis treatment appeared in test group 3 (Example 5-3), test group 4 (Example 5-4), test group 9 (Example 9-3), test group 10 (Example 9-4), test group 15 (Example 13-3) and test group 16 (Example 13-4).
[0165] Based on the conclusions of the colon surgery, the inventors speculate that the reason why test group 3 (Example 5-3) and test group 4 (Example 5-4) had more bleeding points and / or pulsating bleeding points requiring clinical hemostasis treatment was due to the low elastic deformation rate of the obtained biological patch, while the reason why test group 15 (Example 13-3) and test group 16 (Example 13-4) had more bleeding points and / or pulsating bleeding points requiring clinical hemostasis treatment was due to the fact that the elastic deformation rate of the obtained biological patch accounted for a small value of the maximum tensile elongation.
[0166] The reason why test group 9 (Example 9-3) and test group 10 (Example 9-4) had more bleeding points and / or pulsating bleeding points requiring clinical hemostasis treatment may be due to the low elastic deformation rate of the obtained biological patch, or it may be due to the small value of the elastic deformation rate of the obtained biological patch as a percentage of the maximum tensile elongation.
[0167] Clinical trials of rectal surgery have further verified that there is a correlation between the value of elastic deformation rate as a percentage of maximum tensile elongation and bleeding and exudation of the biological patch.
[0168] Since the elastic deformation rate of the biological patch obtained by Example 14 accounts for 50% of the maximum tensile elongation, during rectal surgery, the elastic deformation rate of the biological patch should be controlled within the range of 14.6-39.1%, and the elastic deformation rate should account for no less than 50% of the maximum tensile elongation.
[0169] Table 10: Record of bleeding points during ileal surgery
[0170]
[0171]
[0172]
[0173] It can be seen from Table 10 that during ileal surgery, more bleeding spots requiring clinical hemostasis occurred in test group 9 (Example 9-5) and test group 10 (Example 9-6). The reason is presumed to be that the elastic deformation rate of the biological patch obtained in Example 9 accounts for a small value of the maximum tensile elongation. Therefore, during ileal surgery, the elastic deformation rate of the biological patch should be controlled within the range of 13.7-39.1%, and the value of the elastic deformation rate accounting for the maximum tensile elongation should not be less than 39%.
[0174] Table 11: Record of bleeding points during duodenal surgery
[0175]
[0176]
[0177]
[0178] The experimental results in Table 11 show that more bleeding points and / or pulsating bleeding points requiring clinical hemostasis occurred in test group 9 (Example 9-5), test group 10 (Example 9-6), test group 15 (Example 13-7), and test group 16 (Example 13-8). Therefore, a preliminary conclusion is drawn that when performing duodenal surgery, the elastic deformation rate of the biological patch should be controlled within the range of 13.7-39.1%, and the elastic deformation rate should account for no less than 50% of the maximum tensile elongation.
[0179] Table 12: Record of bleeding points in gastric surgery
[0180]
[0181]
[0182]
[0183]
[0184] The biological patches of test group 1 (Example 1-9), test group 2 (Example 1-10), test group 9 (Example 9-9), and test group 10 (Example 9-10) had tearing at the nail holes and sutures, bleeding and exudation at the anastomosis, and the tearing became more severe over time. However, the biological patches of test group 3 (Example 5-9) and test group 4 (Example 5-10) did not have obvious tearing, so the inventors speculated that during gastric surgery, the single-line suture pulling force of the biological patch should be controlled to be no less than 19.7N.
[0185] As can be seen from Table 12, more bleeding points and / or pulsating bleeding points requiring clinical hemostasis occurred in test group 3 (Examples 5-9), test group 4 (Examples 5-10), test group 9 (Examples 9-9), test group 10 (Examples 9-10), test group 15 (Examples 13-9), test group 16 (Examples 13-10), test group 17 (Examples 14-9), and test group 18 (Examples 14-10). It is speculated that the elastic deformation rate of the biological patch obtained in Example 5 is relatively small. The value of the elastic deformation rate of the biological patch obtained in Examples 13 and 14 as a percentage of the maximum tensile elongation is relatively small. The elastic deformation rate of the biological patch obtained in Example 9 is relatively small or the value of the elastic deformation rate as a percentage of the maximum tensile elongation is relatively small.
[0186] From this, we can draw a preliminary conclusion that during gastric surgery, the single-line suture pulling force of the biological patch should be controlled to be no less than 19.7N, the elastic deformation rate should be in the range of 14.6-39.1%, and the elastic deformation rate should account for no less than 56% of the maximum tensile elongation.
[0187] (3) Mechanical parameters of biopatch required for different digestive surgical sites
[0188] Table 13: Mechanical parameters of biological patches for surgery at different sites
[0189]
[0190]
[0191] Based on the above clinical trial results, a biological patch with a maximum tensile elongation range of 14.8-44.6%, an elastic deformation rate range of 14.6-39.1%, an elastic deformation rate of 56-89% of the maximum tensile elongation, and a single-line suture pulling force of 19.7-54.1N will be suitable for digestive surgical operations including the colon, rectum, ileum, duodenum and stomach.
[0192] VI. Clinical Trial II
[0193] (1) A biological patch with the following parameters is obtained by adjusting the preparation method:
[0194] Table 14: Biomechanical parameters of Examples 18-20
[0195]
[0196] Table 15: Main differences in the preparation methods of Examples 18-20
[0197]
[0198] On the basis of clinical trial 1, 88 patients were further enrolled to further verify the influence of the value of elastic deformation rate to maximum tensile elongation on the clinical application effect.
[0199] Table 16: Results of Clinical Trial 2
[0200]
[0201] Note: The number before “ / ” is the number of cases where the number of bleeding points or pulsating bleeding points required clinical hemostasis was greater than 5. If the number of bleeding points and pulsating bleeding points required clinical hemostasis for the same patient was greater than 5, it was counted as 1 case. The number after “ / ” is the total number of patients.
[0202] The values of elastic deformation rate to maximum tensile elongation of the biological patches obtained in Examples 18 and 19 are lower than the requirements obtained in Clinical Trial 1. It can be seen that the number of bleeding points requiring clinical hemostasis or pulsating bleeding points greater than 5 in digestive surgery at different sites is relatively large. The value of elastic deformation rate to maximum tensile elongation of the biological patch obtained in Example 20 only meets the requirements of colon and ileal surgery. It can be seen that the number of bleeding points requiring clinical hemostasis or pulsating bleeding points greater than 5 in patients undergoing colon and ileal surgery is significantly reduced, while the number of bleeding points requiring clinical hemostasis or pulsating bleeding points greater than 5 in patients undergoing rectal, duodenal and gastric surgery is relatively large.
[0203] Table 16 proves again that the value of elastic deformation rate as a percentage of maximum tensile elongation is indeed related to the bleeding or exudation of the biological patch. If the elastic deformation rate and maximum tensile elongation are too small, the incidence of complications such as anastomotic bleeding and exudation will increase.
[0204] The preferred specific embodiments of the present invention are described in detail above. It should be understood that a person skilled in the art can make many modifications and changes based on the concept of the present invention without creative work. Therefore, any technical solution that can be obtained by a person skilled in the art through logical analysis, reasoning or limited experiments based on the concept of the present invention on the basis of the prior art should be within the scope of protection determined by the claims.
Claims
1. A digestive surgery biological patch, It is characterized in that The maximum tensile elongation of the biological patch is not less than 14.8%, the elastic deformation rate range is not less than 13.7%, and the single-line suture pulling force is greater than 15.6N.
2. The digestive surgery biological patch according to claim 1, It is characterized in that The maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 13.7-39.1%, the single-line suture pulling force ranges from 15.6-54.1N, and the elastic deformation rate accounts for 39-89% of the maximum tensile elongation.
3. The digestive surgery biological patch according to claim 1, It is characterized in that The maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 14.6-39.1%, the single-line suture pulling force ranges from 15.6-54.1N, and the elastic deformation rate accounts for 50-89% of the maximum tensile elongation.
4. The digestive surgery biological patch according to claim 1, It is characterized in that The maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 13.7-39.1%, the single-line suture pulling force ranges from 15.6-54.1N, and the elastic deformation rate accounts for 50-89% of the maximum tensile elongation.
5. The digestive surgery biological patch according to claim 1, It is characterized in that The maximum tensile elongation of the biological patch is 14.8-44.6%, the elastic deformation rate ranges from 14.6-39.1%, the single-line suture pulling force is 19.7-54.1N, and the elastic deformation rate accounts for 56-89% of the maximum tensile elongation.
6. The digestive surgery biological patch according to claim 2, It is characterized in that The digestive surgery biological patch is a colon or ileum surgery biological patch.
7. The digestive surgery biological patch according to claim 3, It is characterized in that The digestive surgery biological patch is a rectal surgery biological patch.
8. The digestive surgery biological patch according to claim 4, It is characterized in that The digestive surgery biological patch is a duodenal surgery biological patch.
9. The digestive surgery biological patch according to claim 5, It is characterized in that The digestive surgery biological patch is a gastric surgery biological patch.
10. The digestive surgery biological patch according to any one of claims 1 to 9, It is characterized in that The digestive surgery biological patch is a biological patch derived from bovine pericardium.
11. The digestive surgery biological patch according to any one of claims 1 to 9, It is characterized in that The digestive surgery biological patch is provided with two through-holes, and the two through-holes are located at two opposite ends of the biological patch.
12. A stapler kit comprising the digestive surgery biological patch according to any one of claims 1 to 9.
13. A method for preparing the digestive surgery biological patch according to any one of claims 1 to 9, It is characterized in that The following steps are involved: (1) Immerse healthy bovine pericardial tissue in hypotonic Hank's solution, rinse and replace the hypotonic Hank's solution repeatedly to fully swell and break up the various cells in the tissue; (2) The tissue slices treated as above are repeatedly rinsed with physiological saline for 60 min to 120 min each time, with the physiological saline changed each time. The total number of rinses is based on the fact that no visible cells, cell components or cell fragments can be seen under the microscope of the tissue slices, and protein and nucleic acid quantitative determination is performed until no soluble protein and nucleic acid can be detected; (3) Using Tween 80, a surfactant solution, to remove phospholipids and nonstructural proteins in the tissue slices as well as some tissue matrix immunogenic molecules such as hyaluronic acid, various chondroitin sulfates, and mucopolysaccharides; (4) Soak in a 0.5-1.5% glutaraldehyde solution for 3-3.5 hours; (5) Place the pretreated tissue material in Cr 3+ The ion concentration is 0.0625 mol / dm 3 , OH / Cr is 0.5 in a hydroxychromium solution, shake in a water bath at 35-42℃ for 3.5-5h; detect the pH of the material treatment solution and use 10% NaHCO 3 The pH was raised by 0.3-0.5 units and then shaken in a water bath at 40-46°C for 60 min.
Citation Information
Cited By
Blood vessel biological patch and preparation thereof
CN119318737A
A vascular biological patch and its preparation
CN119318737B
Thoracic surgical biological patch and preparation method therefor
WO2026032041A1
